This agrees with previous studies that found T‐cell depleted grafts to be associated with decreased incidence of acute GvHD.30, 31, 32, 33 The association was significant in addition to the changes in the initial mean CD4 concentration caused by alemtuzumab, which was received by 53% of the patients with acute GvHD. Here, CD4 is linked to acute graft versus host disease.